Balance Sheet Components

6 Months Ended

Jun. 30, 2025

Balance Sheet Related Disclosures [Abstract]

4. Balance Sheet Components

Property and Equipment, net

Property and equipment, net, consist of the following (in thousands):


	June 30, 2025			December 31, 2024
Laboratory equipment	$	7,888		$	9,745
Office equipment		386			386
Leasehold improvements		286			286
Total property and equipment		8,560			10,417
Less accumulated depreciation and amortization		(6,842	)		(7,278	)
Total	$	1,718		$	3,139

Depreciation expense related to property and equipment was $0.3 million and $0.4 million for each of the three months ended June 30, 2025 and 2024 and $0.7 million and $0.9 million for each of the six months ended June 30, 2025 and 2024.

Sale of Property and Equipment, net

During the three and six months ended June 30, 2025, the Company sold certain laboratory equipment. As a result, the Company recorded proceeds of approximately $1.0 million and incurred a gain on disposal of approximately $0.3 million.

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following (in thousands):


	June 30, 2025		December 31, 2024
Accrued research and development	$	1,553	$	3,761
Accrued compensation		3,295		4,203
Accrued restructuring charges		39		739
Accrued other		500		380
Total	$	5,387	$	9,083

Bolt Biotherapeutics, Inc. 10-Q